NCT06521216View on ClinicalTrials.gov

Different Oral Iron Dosing Regimens in Treatment of Iron Deficency Anemia in Patients With Chronic Kidney Disease

Not yet recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

August 1, 2025

Conditions
CKD
Interventions
DRUG

Ferrous sulfate

all patients will receive 200 mg elemental iron (ferrous sulphate)

All Listed Sponsors
lead

Assiut University

OTHER

NCT06521216 - Different Oral Iron Dosing Regimens in Treatment of Iron Deficency Anemia in Patients With Chronic Kidney Disease | Biotech Hunter | Biotech Hunter